1. The Role of Dexmedetomidine in Tumor-Progressive Factors in the Perioperative Period and Cancer Recurrence: A Narrative Review
    Qiang Cai et al, 2022, Drug Design, Development and Therapy CrossRef
  2. Association between intraoperative dexmedetomidine and all-cause mortality and recurrence after laparoscopic resection of colorectal cancer: Follow-up analysis of a previous randomized controlled trial
    Jingping Hu et al, 2023, Frontiers in Oncology CrossRef
  3. Dexmedetomidine ameliorates liver injury and maintains liver function in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study with propensity score matching
    Xiaoqiang Wang et al, 2023, Frontiers in Oncology CrossRef
  4. Recent Advances in the Clinical Value and Potential of Dexmedetomidine
    Xiaotian Liu et al, 2021, Journal of Inflammation Research CrossRef
  5. Effects of Dexmedetomidine on Immune Cells: A Narrative Review
    Rui Chen et al, 2022, Frontiers in Pharmacology CrossRef
  6. Trial watch: dexmedetomidine in cancer therapy
    Killian Carnet Le Provost et al, 2024, OncoImmunology CrossRef
  7. Circulating biomarkers in perioperative management of cancer patients
    Qiyuan Huang et al, 2023, Precision Clinical Medicine CrossRef
  8. Study of the immune state in different variants of anesthetic support for total laryngectomy
    Yu.Yu. Kobelyatskyi et al, 2023, Medicni perspektivi CrossRef